Serum-Derived Exosomes from Patients with Coronary Artery Disease Induce Endothelial Injury and Inflammation in Human Umbilical Vein Endothelial Cells

• Published in: International Heart Journal Vol. 62; no. 2; pp. 396 - 406
• Main Authors: Zhang, Ping, Liang, Tao, Wang, Xuan, Wu, Tianlong, Xie, Zhixin, Yu, Yanhong, Yu, Huimin
• Format: Journal Article
• Language: English
• Published: Japan International Heart Journal Association 30.03.2021; Japan Science and Technology Agency
• Subjects: Angiogenesis; Atherosclerosis; Cardiovascular disease; Cell migration; Cell Movement; Cell Proliferation; Cell viability; Cells, Cultured; Cholecystokinin; Coronary artery; Coronary Artery Disease - blood; Coronary Artery Disease - pathology; Coronary vessels; Endothelial cells; Exosomes; Exosomes - metabolism; Female; Flow Cytometry; Heart diseases; Human Umbilical Vein Endothelial Cells - metabolism; Human Umbilical Vein Endothelial Cells - pathology; Humans; IL-1β; Inflammation; Inflammation - metabolism; Inflammation - pathology; Inflammatory factors; Intercellular adhesion molecule 1; Interleukin 6; Male; Middle Aged; Pathogenesis; Tumor necrosis factor-α; Umbilical vein; Vascular cell adhesion molecule 1; Vascular endothelial growth factor; Inflammatory factors; Angiogenesis; Pathogenesis; Atherosclerosis
• ISSN: 1349-2365; 1349-3299
• DOI: 10.1536/ihj.20-641

Endothelial injury and inflammation have been found to be essential in the pathogenesis of coronary artery disease (CAD). Circulating exosomes are of great value as novel biomarkers for CAD. However, the role of circulating exosomes in the pathogenesis of CAD remains unclear. Thus, in this study, we aimed to examine whether circulating exosomes from CAD are involved in the endothelial injury and inflammation. The serum-derived exosomes were isolated from CAD and controls using an ExoQuick reagent, and these were then quantified by measuring the protein levels using BCA methods. The uptake of exosomes by human umbilical vein endothelial cells (HUVECs) was observed by laser scanning microscope and analyzed via flow cytometry. Then, HUVECs were treated with vehicle, exosomes from CAD (CAD-exo), and controls (ctrl-exo) in the absence and presence of vascular endothelial growth factor (VEGF). Cell viability, migration, and angiogenesis were evaluated using CCK-8 assay, scratch assay, and tube formation assay. Inflammatory factors including IL-1β, IL-6, TNF-α, ICAM-1, and VCAM-1 levels were detected via qPCR. As per our findings, no significant differences were noted in uptake of ctrl-exo and CAD-exo by HUVECs. CAD-exo suppressed cell viability in a dose-dependent manner. Compared with ctrl-exo, CAD-exo-treated HUVECs significantly suppressed migration and angiogenesis. However, CAD-exo had a stronger inhibitory effect on VEGF-induced migration and angiogenesis compared with ctrl-exo. Moreover, IL-1β, TNF-α, and ICAM-1 were determined to be significantly upregulated in HUVECs treated with CAD-exo, but IL-6 and VCAM-1 expressions were not affected. Overall, our results suggest that CAD-exo are involved in endothelial injury and inflammation, which may, in turn, cause endothelial dysfunction and potentially promote the development of CAD.